Using MANOVAs with repeated measures, no interaction effect for clinical knowledge, confidence in clinical skills, and motivation for future learning were found, both groups displaying significantly enhanced cognition and motivation.
Both experimental groups displayed significantly superior histological results compared with the control group.
Both of these groups displayed significantly increased T cell activation, compared to normal, term infants.
Both the 12 hr and 6 hr phase-advanced groups displayed significantly reduced recall compared to the un-shifted control group on the first day of testing (12 hr shift: t15 = 6.62, P<0.001; 6 hr advance: t14 = 4.28, P<0.001).
These three groups displayed significantly different 5-year survival rates of 92%, 57% and 20%, respectively (p <0.001)(Figure 2). Figure 2 At follow up, Kaplan-Meier curves showing patient survival probability stratified by BSI categories.
However, when LORR was measured on PN50 and PN62, 4.0 and 3.0 g/kg treatment groups displayed significantly less LORR compared to the free feeding and 1.0 g/kg ethanol treated groups.
However, the NCM-3 and NCM-6 days groups displayed significantly lower numbers of axons when compared with the stem cell group (Fig. 3M, N).
The NCM-3 and NCM-6 days groups displayed significantly higher numbers of axons when compared with the control group (Fig. 3M, N).
In the probe trial, standard housed WT and enriched WT or APPSw,Ind groups displayed significantly higher permanencies in the target quadrant compared to other platform locations (p<0.0001), whereas standard housed APPSw,Ind mice failed to show such a preference (p>0.05) (Fig. 1D).
Nontreated groups displayed significantly greater edema levels in comparison to the sham group (nodectomy 219.8 ± 118.7 and HAMC 162.6 ± 141).
